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Abstract. Background/Aim: Guaiazulene (1,4-dimethyl-7-
isopropylazulene) is present in several essential oils of
medicinal and aromatic plants. There exist few studies that
investigated the anticancer activity of guaiazulenes. We
investigated the relative cytotoxicity of 10 alkylaminoguai -
azulene derivatives towards both cancer and normal cells.
Materials and Methods: Cytotoxicity towards four human
oral squamous cell carcinoma (OSCC) cell lines and five
types of human normal oral cells (gingival fibroblasts,
periodontal ligament fibroblasts, pulp cells and
keratinocytes, gingival epithelial progenitors) was
determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) method. Tumor
specificity (TS) was evaluated as the ratio of the mean 50%
cytotoxic concentration against normal oral cells to that
against OSCC cell lines. Apoptosis-inducing activity was
evaluated by cleavage of poly ADP-ribose polymerase and
caspsase-3 with western blot analysis. Results: Validity of
the present TS measurement method was confirmed using
methotrexate. With increasing length of the alkyl group of
alkylaminoguaiazulene derivatives, cytotoxicity increased.
Introduction of oxygen, nitrogen or sulfur atom into the
alkyl group slightly reduced cytotoxicity. Most compounds
had very low TS, no synergistic action with methotrexate
and doxorubicin, nor did they induce apoptosis of OSCC
cells. On the other hand, compound [10], containing a
morpholino group, induced apoptosis of OSCC cells.
Conclusion: The cytotoxicity of alkylaminoguaiazulenes is
not always coupled with TS and apoptosis-inducing activity. 
Guaiazulene (1,4-dimethyl-7-isopropylazulene), present in
several essential oils of medicinal and aromatic plants, is
widely used as a natural ingredient in many healthcare
products. There are limited numbers of studies that have
investigated the cytotoxicity of guiazulene. Guaiazulenes are
highly toxic to human leukemia cell lines (HL-60. K562)
(1), freshly prepared rat neuron cells and neuroblastoma cell
lines (2), and human gingival fibroblasts (3); toxicity
against fibroblasts was partially reversible by UV irradiation
(3). We previously reported that methyl 7-isopropyl-2-
methoxyazulene-1-carboxylate had higher tumor-specific
cytotoxicity than azulene and guaiazulene, and induced
apoptosis of HL-60 cells, possibly by non-radical-mediated
mechanism (4). 
In order to search for tumor-selective guaiazulene
derivatives, we synthesized 10 alkylaminoguaiazulenes
(Figure 1) and investigated their anticancer activity.
Validation of apoptosis research seems to derive from reports
that apoptosis induced by anticancer agents is also detected
in clinical cancer tissue (5). Therefore, we also investigated
apoptosis induction by these compounds. 
Materials and Methods
Materials. The following chemicals and reagents were obtained
from the indicated companies: Dulbecco’s modified Eagle’s medium
(DMEM) from GIBCO BRL, Grand Island, NY, USA; fetal bovine
serum (FBS), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT), doxorubicin-HCl from Sigma-Aldrich Inc., St.
Louis, MO, USA; dimethyl sulfoxide (DMSO) from Wako Pure
Chem. Ind., Osaka, Japan; methotrexate from Nacalai Tesque, Inc.,
Kyoto, Japan. Culture plastic dishes and plates (96-well) were
purchased from Becton Dickinson (Franklin Lakes, NJ, USA).
Protease and phosphatase inhibitors were purchased from Roche
Diagnostics (Tokyo, Japan). Antibodies against cleaved caspase-3
(Cell Signaling Technology Inc., Beverly, MD, USA), poly ADP-
ribose polymerase (PARP; Cell Signaling Technology Inc.) and
glyceraldehyde 3-phosphate dehydrogenase (GAPDH; Trevigen,
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Gaithersburg, MD, USA) were used as primary antibodies. As
secondary antibodies, horseradish peroxidase-conjugated α-rabbit
IgG (DAKO, Tokyo, Japan) antibodies were used.
Synthesis of alkylaminoguaiazulenes. 3-(2-Aminoethylamino)methyl-
guaiazulene [1], 3-(3-aminopropylamino)methylguaiazulene [2], 3-(4-
aminobutylamino)methylguaiazulene [3], 3-(5-aminopentylamino)





mino)methylguaiazulene [10] were synthesized according to previous
reports (6-8). All compounds were dissolved in DMSO at 40 mM and
stored at –20˚C before use.
Cell culture. Human gingival fibroblast (HGF), periodontal ligament
fibroblast (HPLF) and pulp (HPC) cells, established from the first
premolar tooth extracted from the lower jaw of a 12-year-old girl
(9), and OSCC cell lines (Ca9-22, HSC-2, HSC-3, HSC-4),
purchased from Riken Cell Bank, Tsukuba, Japan, were cultured at
37˚C in DMEM supplemented with 10% heat-inactivated FBS, 100
units/ml, penicillin G and 100 μg/ml streptomycin sulfate under a
humidified atmosphere with 5% CO2. Human oral keratinocyte
(HOK) cells (purchased from COSMO BIO Co/Ltd., Tokyo, Japan)
were cultured in oral keratinocyte growth supplement (OKGS), and
human primary gingival epithelial (HGEP) cells (purchased from
CELLnTEC Advanced Cell Systems AG, Bern, Switzerland) were
grown in CnT-PR medium (CELLnTEC) (10-12). HGF, HPLF and
HPC at 12-20 population doubling level, and HOK and HGEP at 
7-11 population doubling level were used in the present study.
Assay for cytotoxic activity. Cells were inoculated at 2×103 cells/0.1
ml in a 96-microwell plate (Becton Dickinson Labware), since
inoculation of cells at higher cell density resulted in inaccurate
estimation of viable cell number (Figure 2). After 48 h, the medium
was removed by suction with an aspirator and replaced with 0.1 ml
of fresh medium containing different concentrations of the test
compounds. Control cells were treated with the same amounts of
DMSO present in each diluent solution. Cells were incubated for 48
h and the relative viable cell number was then determined by the
MTT method. In brief, the treated cells were incubated for another
2 h in fresh culture medium containing 0.2 mg/ml MTT. Cells were
then lysed with 0.1 ml of DMSO and the absorbance at 562 nm of
the cell lysate was determined using a microplate reader (Sunrise
Rainbow RC-R; TECAN, Mannedorf, Switzerland). The 50%
cytotoxic concentration (CC50) was determined from the dose–
response curve of triplicate or quadruplicate samples.
Calculation of tumor-selectivity index (TS). TS was calculated
using the following equation: TS=mean CC50 against three normal
oral cells/mean CC50 against OSCC cell lines [(D/B) in Table I].
Since both Ca9-22 and HGF cells were derived from gingival
tissue (13), the relative sensitivity of these cells was also compared
[(C/A) in Table I]. We did not use human normal oral keratinocytes
for tumor-specificity assay, since many anticancer drugs showed
potent cytotoxicity against normal keratinocytes by inducing
apoptosis (14). 
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Figure 1. Structure of alkylaminoguaiazulenes.
Figure 2. Dose–response curve of cytotoxicity induction by methotrexate
in cells inoculated at different density. HSC-3 cells were inoculated at
1, 2, 4 or 8×103/well in 96-microwell plate [very low (LL), low (L),
high (H) or very high (HH) cell density] and incubated for 48 h to allow
the complete cell attachment. Cells were then exposed for 48 h to the
indicated concentrations of methotrexate to determine the viable cell
number at 562 nm by MTT method. Each value represents mean±S.D of
quadruplicate determinations. 
Western blot analysis. The treated with cells were washed with
phosphate-buffered saline and re-suspended in 50 mM Tris-HCl (pH
7.6), 150 mM NaCl, 1 mM EDTA, 0.1% sodium dodecyl sulfate,
0.5% deoxycholic acid, 1% NP-40 and protease inhibitors (RIPA
buffer). After ultrasonication using Bioruptor (UCD-250; Cosmo
Bio) for 12.5 min (10 s on, 20 s off) at the middle level of output
(250 W) at 4˚C, the soluble cellular extracts were recovered after
centrifugation for 10 min at 16,000 × g. The protein concentration
of each sample was determined using BCA Protein Assay Reagent
Kit (Thermo Fisher Scientific, Waltham, MA, USA) and cell
extracts were subjected to western blot analysis. The blots were
probed with the primary antibody followed by a horseradish
peroxidase-conjugated secondary antibody. The immune complexes
were visualized using Pierce Western Blotting Substrate Plus
(Thermo Fisher Scientific). Western blot results were documented
and quantified using ImageQuant LAS 500 (GE Healthcare, Tokyo,
Japan) (15).
Statistical treatment. Each experimental value is expressed as the
mean±standard deviation (SD) of triplicate or quadruplicate
determinations. CompuSyn software (ComboSyn, Inc., Paramus, NJ,
USA) was used to calculate the combination index (CI) (16).
Briefly, the CI value was determined by the following equation:
CI=(ΔNA + ΔNB/ΔNAB), where ΔNA is the percentage decrease in
viable cell number induced by compound A, ΔNB is that induced
by compound B, and ΔNA is that induced by their combination. The
combination effect was judged as synergistic, additive or
antagonistic when the CI was <1, 1 and >1, respectively. 
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Table I. Time-dependent induction of cytotoxicity by methotrexate. Each value represents the mean from triplicate assays.
                                                                                                                                                                      CC50 of methotrexate (μM)
                                                                                                                                             24 h                       48 h                      72 h                      96 h
Human oral squamous cell carcinoma cells                                   Ca9-22                       >400                       230                       <6.3                      <6.3
                                                                                                          HSC-2                       >400                       253                       <6.3                      <6.3
                                                                                                          HSC-3                       >400                      <6.3                      <6.3                      <6.3
                                                                                                          HSC-4                       >400                      <6.3                      <6.3                      <6.3
Human normal oral epithelial cells                                                  HOK                        >400                       291                        50                        302
                                                                                                          HGEP                       >400                      <6.3                      <6.3                      <6.3
Human normal oral messenchymal cells                                          HGF                         >400                     >400                      249                      >400
                                                                                                           HPLF                        >400                     >400                     >400                     >400
                                                                                                            HPC                         >400                     >400                     >400                     >400
HOK, Human oral keratinocytes; HGEP: primary human gingival epithelial cells; HGF: human gingival fibroblasts; HPLF: periodontal ligament
fibroblasts; HPC: pulp cells; CC50. 50% cytotoxic concentration.
Table II. Cytotoxicity of alkylaminoguaiazulenes and doxorubicin against human oral squamous cell carcinoma (OSCC) cell lines and human normal
oral cells.
                                                  Human OSCC cell lines                                                       Human normal oral cells                                        
                                                                                                                                                                                                                              TS
Compound       Ca9-22       HSC-2        HCS-3          HSC-4          Mean            HGF             HPLF           HPC              Mean 
                            (A)                                                                      (B)                (C)                                                        (D)            (D/B)        (C/A)
1                         11.11           9.28           11.71            10.52          10.65             25.44             15.26            18.56             19.75            1.85           2.29
2                         10.92           8.38             7.13              6.49            8.23             13.91             25.56            10.21             16.56            2.01           1.27
3                           4.52           3.87             4.15              3.74            4.07               5.11               4.1                4.56               4.59            1.13           1.13
4                           2.66           2.13             2.04              1.95            2.19               3.02               2.36              2.27               2.55            1.16           1.14
5                           1.91           2.19             1.43              1.32            1.71               2.36               1.34              1.68               1.79            1.05           1.23
6                           4.26           3.98             3.13              3.3              3.67               4.81               3.28              3.67               3.92            1.07           1.13
7                           9.64           7.3               6.27              7.02            7.56              11.51               9.16            10.51             10.39            1.38           1.19
8                           8.16         10.26             8.93              8.36            8.93             17.52             13.87            13.88             15.09            1.69           2.15
9                           4.79           4.9               5.2                4.26            4.78               7.25               5.85              6.67               6.59            1.38           1.51
10                      14.88         20.72           13.75            11.82          15.29             38.84             30.5              37.16             35.5              2.32           2.61
DXR                    0.06           0.04             0.03              -                 0.04               0.54               -                   1.43               0.99          22.81           9.21
Each value represents the mean from triplicate assays. Ca9-22, HSC-2, HSC-3 and HSC-4: Oral squamous cell carcinoma cell lines; HGF: human
gingival fibroblasts; HPLF: periodontal ligament fibroblasts; HPC: pulp cells; CC50. 50% cytotoxic concentration; DXR: doxorubicin-HCl.
Results
Validity of the present method of TS evaluation. We first
confirmed that the present assay system for TS evaluation
reflects the actual anticancer activity of test samples. When
HSC-2 cells were incubated for 24, 48, 72 or 96 h without
(control) or with 6.25, 12.5, 50, 100, 200 or 400 μM
methotrexate, a popular antitumor agent, its cytotoxicity was
increased with prolongation of treatment time (Figure 3).
Methotrexate showed higher cytotoxicity against four human
OSCC cell lines (Ca9-22, HSC-2, HSC-3, HSC-4) compared to
human mesenchymal normal oral cells (HGF, HPLF and HPC).
Human normal epithelial cells such HOK, and especially HGEP
were very sensitive to methotrexate (Table I), confirming our
previous report (14). Based on these data, we assayed the
cytotoxicity of 10 alkylamino-guaiazulenes using four OSCC
cell lines and three types of mesenchymal normal oral cells. 
Cytotoxicity. When the length of the side chain alkyl group
was increased, the cytotoxicity also increased (see
compounds [1]-[5] in Figure 1); the CC50 decreased in the
order [1], [2], [3], [4] and [5], [5] with six methylene groups
was the most cytotoxic. Modified compounds of [5] with
oxygen, nitrogen and sulfur atoms introduced into alkyl
chains, such as compounds [6]-[9] showed slightly lower
cytotoxicity. Compound [10] having a morpholine backbone
showed much reduced cytotoxicity (Table II). 
Tumor specificity. TS was determined by dividing the mean
CC50 value towards three normal cells by the mean CC50
in vivo 32: 541-547 (2018)
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Figure 3. Time-dependent increase of cytotoxicity of methotrexate. A total nine different cells were inoculated at 2×103/well in 96-microwell plate
and incubated for 48 h to allow the complete cell attachment. Cells were then exposed for 48 h to the indicated concentrations of methotrexate to
determine the viable cell number at 562 nm by MTT method. Each value represents mean of triplicate determinations. SD: <10%.
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Figure 4. Antagonistic interaction of compound [2] and anticancer drugs. Near-confluent HSC-4 cells were incubated for 48 h with the indicated
concentrations of methotrexate (A) or doxorubicin (B) in the presence of 0. 6.25, 12.5, 25 or 50 μM of [2] and, then viable cell number was
determined by the MTT method. Each value represents mean of triplicate assays. SD: <10%. From the dose–response curve, combination index
(CI) was determined and plotted as a function of methotrexate or doxorubicin concentration. 
Figure 5. Induction of apoptosis by alkylaminoguaiazulenes in HSC-2 cells. Near-confluent HSC-2 cells were incubated for 24 h with the indicated
concentrations of alkylaminoguaiazulenes and expression of cleaved products of poly ADP-ribose polymerase (PARP) and caspase-3 was visualized
by western blot analysis. Each sample contains 0.1% DMSO. Act.D., Actinomycin D (1 μM), was used as a positive control for apoptosis.
value towards four OSCC cell lines (D/B, Table I).
Considering that HGF is the normal cell type corresponding
to cancer cell Ca9-22 (both derived from gingival tissues), the
TS value was also generated by dividing the average CC50
value for HGF cells by that for Ca9-22 cells (C/A, Table I).
All 10 compounds showed very weak tumor specificity as
compared with doxorubicin (TS=1.05~2.32 in D/B;
TS=1.13~2.61 in C/A) (Table II). 
Antagonistic action of alkylaminoguaiazulenes with
anticancer drugs. Compound [2], having the highest TS
value among compounds [1]-[5], did not enhance the
cytotoxic activity of methotrexate or doxorubicin, as judged
by the high CI (CI>1) (Figure 4).
Apoptosis induction. Compound [10], having the highest TS
value among compounds [6]-[10], induced the cleavage of
PARP and caspsase-3, suggesting the induction of apoptosis
(Figure 5) (17).
Discussion
Ten alkylamino-guaiazulenes used here showed potent
cytotoxicity against both cancer and normal cells, thus
yielding very low tumor specificity (TS=1.05-2.29). Their
cytotoxicity was increased with increasing length of the
alkylamino group. This conclusion was further substantiated
by our preliminary observation that cytotoxicity of
benzo[b]cyclohept[e][1,4] oxazines was increased with
elongation of the methylene side chain (Figure 6), and none
of them induced apoptosis (as assessed with DNA
fragmentation and caspase activation experiments), like
compound [5] demonstrated here.
We also found that [2], with the highest TS value among
compounds [1]-[5] did not exhibit synergistic action with
anticancer drugs (Figure 4). This reduces the possibility of
clinical application of these compounds. However, we found
that compound [10], with a morpholino group, led to
apoptosis-inducing activity as well as higher TS values
(Figure 5). This finding is in agreement with a recent report
that various compounds having morpholine moieties had
antiproliferative effect through G2/M cell-cycle arrest (18),
apoptosis and autophagy induction (19) and high tumor
specificity (20). The mechanism of induction of apoptosis
and tumor specificity by [10] remains to be investigated.
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